{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Chronic obstructive pulmonary disease (COPD)", "Fasudil", "Hypoxia", "Inflammation", "Ozone", "Pulmonary hypertension"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27286659", "DateCompleted": {"Year": "2017", "Month": "05", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2016", "Month": "06", "Day": "07"}], "ELocationID": ["10.1016/j.taap.2016.06.003", "S0041-008X(16)30137-5"], "Journal": {"ISSN": "1096-0333", "JournalIssue": {"Volume": "305", "PubDate": {"Year": "2016", "Month": "Aug", "Day": "15"}}, "Title": "Toxicology and applied pharmacology", "ISOAbbreviation": "Toxicol Appl Pharmacol"}, "ArticleTitle": "Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure.", "Pagination": {"StartPage": "40", "EndPage": "45", "MedlinePgn": "40-45"}, "Abstract": {"AbstractText": ["Ozone (O3)-related cardiorespiratory effects are a growing public health concern. Ground level O3 can exacerbate pre-existing respiratory conditions; however, research regarding therapeutic interventions to reduce O3-induced lung injury is limited. In patients with chronic obstructive pulmonary disease, hypoxia-associated pulmonary hypertension (HPH) is a frequent comorbidity that is difficult to treat clinically, yet associated with increased mortality and frequency of exacerbations. In this study, we hypothesized that established HPH would confer vulnerability to acute O3 pulmonary toxicity. Additionally, we tested whether improvement of pulmonary endothelial barrier integrity via rho-kinase inhibition could mitigate pulmonary inflammation and injury. To determine if O3 exacerbated HPH, male C57BL/6 mice were subject to either 3 weeks continuous normoxia (20.9% O2) or hypoxia (10.0% O2), followed by a 4-h exposure to either 1ppm O3 or filtered air (FA). As an additional experimental intervention fasudil (20mg/kg) was administered intraperitoneally prior to and after O3 exposures. As expected, hypoxia significantly increased right ventricular pressure and hypertrophy. O3 exposure in normoxic mice caused lung inflammation but not injury, as indicated by increased cellularity and edema in the lung. However, in hypoxic mice, O3 exposure led to increased inflammation and edema, along with a profound increase in airway hyperresponsiveness to methacholine. Fasudil administration resulted in reduced O3-induced lung injury via the enhancement of pulmonary endothelial barrier integrity. These results indicate that increased pulmonary vascular pressure may enhance lung injury, inflammation and edema when exposed to pollutants, and that enhancement of pulmonary endothelial barrier integrity may alleviate such vulnerability."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States."}], "LastName": "Zychowski", "ForeName": "Katherine E", "Initials": "KE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States."}], "LastName": "Lucas", "ForeName": "Selita N", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States."}], "LastName": "Sanchez", "ForeName": "Bethany", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States."}], "LastName": "Herbert", "ForeName": "Guy", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States. Electronic address: mcampen@salud.unm.edu."}], "LastName": "Campen", "ForeName": "Matthew J", "Initials": "MJ"}], "GrantList": [{"GrantID": "K12 GM088021", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES014639", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R56 ES014639", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Toxicol Appl Pharmacol", "NlmUniqueID": "0416575", "ISSNLinking": "0041-008X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "84477-87-2", "NameOfSubstance": "1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "rho-Associated Kinases"}, {"RegistryNumber": "Q0CH43PGXS", "NameOfSubstance": "fasudil"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "pharmacology", "therapeutic use"], "DescriptorName": "1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"}, {"QualifierName": ["toxicity"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "drug therapy", "pathology", "physiopathology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Cell Count"}, {"QualifierName": ["drug therapy", "etiology", "pathology", "physiopathology"], "DescriptorName": "Hypertension, Pulmonary"}, {"QualifierName": ["chemically induced", "drug therapy", "pathology", "physiopathology"], "DescriptorName": "Hypertrophy, Right Ventricular"}, {"QualifierName": ["complications", "drug therapy", "pathology", "physiopathology"], "DescriptorName": "Hypoxia"}, {"QualifierName": ["drug effects", "pathology", "physiopathology"], "DescriptorName": "Lung"}, {"QualifierName": ["chemically induced", "drug therapy", "pathology", "physiopathology"], "DescriptorName": "Lung Injury"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug effects"], "DescriptorName": "Organ Size"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ventricular Function, Right"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ventricular Pressure"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "rho-Associated Kinases"}], "CoiStatement": "<b>Conflicts of Interest Statement</b>. The authors declare no conflicts of interest with the contents of this manuscript."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, Kaibuchi K, Shimokawa H. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. Journal of cardiovascular pharmacology. 2006;48:280\u2013285.", "ArticleIdList": ["17204906"]}, {"Citation": "Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, Zmirou D, Touloumi G, Wojtyniak B, Ponka A. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. European respiratory journal. 1997;10:1064\u20131071.", "ArticleIdList": ["9163648"]}, {"Citation": "Bauer AK, Kleeberger SR. Genetic mechanisms of susceptibility to ozone-induced lung disease. Ann N Y Acad Sci. 2010;1203:113\u2013119.", "ArticleIdList": ["20716292"]}, {"Citation": "Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barber\u00e0 JA. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. American journal of respiratory and critical care medicine. 2010;181:270\u2013278.", "ArticleIdList": ["19875684"]}, {"Citation": "Campen MJ, Costa DL, Watkinson WP. Cardiac and Thermoregulatory Toxicity of Residual Oil Fly Ash in Cardiopulmonary-Compromised Rats. Inhal Toxicol. 2000;12(Suppl 2):7\u201322.", "ArticleIdList": ["26368518"]}, {"Citation": "Campen MJ, Shimoda LA, O\u2019Donnell CP. Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol. 2005;99:2028\u20132035.", "ArticleIdList": ["16002771"]}, {"Citation": "Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. European Respiratory Journal. 2008;32:1371\u20131385.", "ArticleIdList": ["18978137"]}, {"Citation": "Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. New England Journal of Medicine. 1992;327:70\u201375.", "ArticleIdList": ["1603138"]}, {"Citation": "Dell SDM, Gershon AS, Chen H, To T, Foty RG. The Reported Perceptions And Behaviours Of Canadians With COPD Towards The Health Effects Of Air Pollution. Am J Respir Crit Care Med. 2015;191:A2296."}, {"Citation": "Desqueyroux H, Pujet JC, Prosper M, Le Moullec Y, Momas I. Effects of air pollution on adults with chronic obstructive pulmonary disease. Archives of environmental health. 2002;57:554\u2013560.", "ArticleIdList": ["12696653"]}, {"Citation": "Ding RY, Zhao DM, Zhang ZD, Guo RX, Ma XC. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice. Journal of Surgical Research. 2011;171:e209\u2013e214.", "ArticleIdList": ["21962807"]}, {"Citation": "Fabbri LM, Aizawa H, Alpert SE, Walters EH, O\u2019Byrne PM, Gold BD, Nadel JA, Holtzman MJ. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. The American review of respiratory disease. 1984;129:288\u2013291.", "ArticleIdList": ["6696327"]}, {"Citation": "Fujii M, Duris K, Altay O, Soejima Y, Sherchan P, Zhang JH. Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats. Neurochemistry international. 2012;60:327\u2013333.", "ArticleIdList": ["PMC3288616", "22226843"]}, {"Citation": "Fujita H, Fukumoto Y, Saji K, Sugimura K, Demachi J, Nawata J, Shimokawa H. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension. Heart and vessels. 2010;25:144\u2013149.", "ArticleIdList": ["20339976"]}, {"Citation": "Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart. 2005;91:391\u2013392.", "ArticleIdList": ["PMC1768747", "15710736"]}, {"Citation": "Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS. Guidelines for the diagnosis and treatment of pulmonary hypertension. European heart journal. 2009;30:2493\u20132537.", "ArticleIdList": ["19713419"]}, {"Citation": "Galvin I, Drummond GB, Nirmalan M. Distribution of blood flow and ventilation in the lung: gravity is not the only factor. British journal of anaesthesia. 2007;98:420\u2013428.", "ArticleIdList": ["17347182"]}, {"Citation": "Gardner SY, McGee JK, Kodavanti UP, Ledbetter A, Everitt JI, Winsett DW, Doerfler DL, Costa DL. Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension. Environ Health Perspect. 2004;112:872\u2013878.", "ArticleIdList": ["PMC1242015", "15175175"]}, {"Citation": "Gibson CL, Srivastava K, Sprigg N, Bath PM, Bayraktutan U. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions. J Neurochem. 2014;129:816\u2013826.", "ArticleIdList": ["24528233"]}, {"Citation": "Gosens R, Schaafsma D, Bromhaar MMG, Vrugt B, Zaagsma J, Meurs H, Nelemans SA. Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent. European journal of pharmacology. 2004;494:73\u201376.", "ArticleIdList": ["15194453"]}, {"Citation": "Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279:509\u2013514.", "ArticleIdList": ["9438836"]}, {"Citation": "Halonen JI, Lanki T, Yli-Tuomi T, Kulmala M, Tiittanen P, Pekkanen J. Urban air pollution and asthma and COPD hospital emergency room visits. Thorax 2008", "ArticleIdList": ["18267984"]}, {"Citation": "Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N, Nakano T. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circulation Journal. 2006;70:174\u2013178.", "ArticleIdList": ["16434811"]}, {"Citation": "Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. American journal of respiratory and critical care medicine. 2001;164:S28\u2013S38.", "ArticleIdList": ["11734464"]}, {"Citation": "Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. Journal of cardiovascular pharmacology. 2007;49:85\u201389.", "ArticleIdList": ["17312448"]}, {"Citation": "Kasahara DI, Mathews JA, Park CY, Cho Y, Hunt G, Wurmbrand AP, Liao JK, Shore SA. ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2015;309:L736\u2013L746.", "ArticleIdList": ["PMC4593838", "26276827"]}, {"Citation": "Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 1999;159:158\u2013164.", "ArticleIdList": ["9872834"]}, {"Citation": "Kodavanti UP, Jackson MC, Ledbetter AD, Richards JR, Gardner SY, Watkinson WP, Campen MJ, Costa DL. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension. J Toxicol Environ Health A. 1999;57:543\u2013563.", "ArticleIdList": ["10515573"]}, {"Citation": "Li Y, Yao JH, Hu XW, Fan Z, Huang L, Jing HR, Liu KX, Tian XF. Inhibition of Rho kinase by fasudil hydrochloride attenuates lung injury induced by intestinal ischemia and reperfusion. Life sciences. 2011;88:104\u2013109.", "ArticleIdList": ["21056587"]}, {"Citation": "Lund AK, Lucero J, Lucas S, Madden MC, McDonald JD, Seagrave JC, Knuckles TL, Campen MJ. Vehicular Emissions Induce Vascular MMP-9 Expression and Activity Associated With Endothelin-1\u2013Mediated Pathways. Arteriosclerosis, thrombosis, and vascular biology. 2009;29:511\u2013517.", "ArticleIdList": ["PMC4103743", "19150882"]}, {"Citation": "Malig BJ, Pearson DL, Chang YB, Broadwin R, Basu R, Green RS, Ostro B. A Time-Stratified Case-Crossover Study of Ambient Ozone Exposure and Emergency Department Visits for Specific Respiratory Diagnoses in California (2005\u20132008) Environ Health Perspect 2015", "ArticleIdList": ["PMC4892911", "26647366"]}, {"Citation": "McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. CHEST Journal. 2007;132:1748\u20131755.", "ArticleIdList": ["17890477"]}, {"Citation": "Mishra NC, Langley RJ, Singh SP, Pe\u00f1a-Philippides JC, Koga T, Razani-Boroujerdi S, Hutt J, Campen M, Kim KC, Tesfaigzi Y. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. The Journal of Immunology. 2008;180:7655\u20137663.", "ArticleIdList": ["PMC2614131", "18490768"]}, {"Citation": "Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. American journal of respiratory and critical care medicine. 2005;171:494\u2013499.", "ArticleIdList": ["15563635"]}, {"Citation": "Paffett ML, Channell MM, Naik JS, Lucas SN, Campen MJ. Cardiac and vascular atrogin-1 mRNA expression is not associated with dexamethasone efficacy in the monocrotaline model of pulmonary hypertension. Cardiovascular toxicology. 2012a;12:226\u2013234.", "ArticleIdList": ["PMC3405193", "22311109"]}, {"Citation": "Paffett ML, Hesterman J, Candelaria G, Lucas S, Anderson T, Irwin D, Hoppin J, Norenberg J, Campen MJ. Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension. PloS one. 2012b;7:e40910.", "ArticleIdList": ["PMC3398888", "22815866"]}, {"Citation": "Peacock JL, Anderson HR, Bremner SA, Marston L, Seemungal TA, Strachan DP, Wedzicha JA. Outdoor air pollution and respiratory health in patients with COPD. Thorax. 2011 thx-2010.", "ArticleIdList": ["21459856"]}, {"Citation": "Sapey E, Stockley RA. COPD exacerbations\u00b7 2: Aetiology. Thorax. 2006;61:250\u2013258.", "ArticleIdList": ["PMC2080749", "16517585"]}, {"Citation": "Satoh SI, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, Sasaki Y, Asano T. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life sciences. 2001;69:1441\u20131453.", "ArticleIdList": ["11531167"]}, {"Citation": "Schaafsma D, Gosens R, Bos IST, Meurs H, Zaagsma J, Nelemans SA. Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. British journal of pharmacology. 2004;143:477\u2013484.", "ArticleIdList": ["PMC1575413", "15381630"]}, {"Citation": "Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, Kramer U. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res. 2005;6:152.", "ArticleIdList": ["PMC1352358", "16372913"]}, {"Citation": "Schwenke DO, Pearson JT, Mori H, Shirai M. Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice. J Pharmacol Toxicol Methods. 2006;53:277\u2013283.", "ArticleIdList": ["16338149"]}, {"Citation": "Seeger W, Adir Y, Barber\u00e0 JA, Champion H, Coghlan JG, Cottin V, De Marco T, Gali\u00e8 N, Ghio S, Gibbs S. Pulmonary hypertension in chronic lung diseases. Journal of the American College of Cardiology. 2013:62.", "ArticleIdList": ["24355635"]}, {"Citation": "Shibuya M, Hirai S, Seto M, Satoh S-i, Ohtomo E Fasudil Ischemic Stroke Study G. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. Journal of the neurological sciences. 2005;238:31\u201339.", "ArticleIdList": ["16005902"]}, {"Citation": "Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M. A randomised, controlled trial of bosentan in severe COPD. European Respiratory Journal. 2008;32:619\u2013628.", "ArticleIdList": ["18448495"]}, {"Citation": "Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Anto JM. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. American journal of epidemiology. 1993;137:701\u2013705.", "ArticleIdList": ["8484361"]}, {"Citation": "Tasaka S, Koh H, Yamada W, Shimizu M, Ogawa Y, Hasegawa N, Yamaguchi K, Ishii Y, Richer SE, Doerschuk CM. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. American journal of respiratory cell and molecular biology. 2005;32:504\u2013510.", "ArticleIdList": ["15778497"]}, {"Citation": "Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, Mariotta S, Ricci A, Vitarelli A, Puglisi G. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung. 2010;188:321\u2013329.", "ArticleIdList": ["20066539"]}, {"Citation": "Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531\u20131536.", "ArticleIdList": ["15888824"]}, {"Citation": "Tuder RM, Yun JH, Bhunia A, Fijalkowska I. Hypoxia and chronic lung disease. Journal of Molecular Medicine. 2007;85:1317\u20131324.", "ArticleIdList": ["18040654"]}, {"Citation": "Weitzenblum E, Chaouat A. Severe pulmonary hypertension in COPD: is it a distinct disease? Chest. 2005;127:1480\u20131482.", "ArticleIdList": ["15888814"]}, {"Citation": "Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E. Pulmonary arterial enlargement and acute exacerbations of COPD. New England Journal of Medicine. 2012;367:913\u2013921.", "ArticleIdList": ["PMC3690810", "22938715"]}, {"Citation": "Williams AS, Mathews JA, Kasahara DI, Wurmbrand AP, Chen L, Shore SA. Innate and ozone-induced airway hyperresponsiveness in obese mice: role of TNF-\u03b1. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2015;308:L1168\u2013L1177.", "ArticleIdList": ["PMC4451401", "25840999"]}, {"Citation": "Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascular pharmacology. 2002;39:187\u2013199.", "ArticleIdList": ["12747959"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "3", "Day": "2"}, {"Year": "2016", "Month": "5", "Day": "10"}, {"Year": "2016", "Month": "6", "Day": "3"}, {"Year": "2016", "Month": "6", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27286659", "NIHMS795417", "PMC4961626", "10.1016/j.taap.2016.06.003", "S0041-008X(16)30137-5"]}}], "PubmedBookArticle": []}